Detalles de la búsqueda
1.
Early Change in Urine Protein as a Surrogate End Point in Studies of IgA Nephropathy: An Individual-Patient Meta-analysis.
Am J Kidney Dis
; 68(3): 392-401, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27032886
2.
GFR decline as an alternative end point to kidney failure in clinical trials: a meta-analysis of treatment effects from 37 randomized trials.
Am J Kidney Dis
; 64(6): 848-59, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25441438
3.
GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
Am J Kidney Dis
; 64(6): 860-6, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25441439
4.
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT).
Am J Kidney Dis
; 63(2): 244-50, 2014 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-24210590
Resultados
1 -
4
de 4
1
Próxima >
>>